214 related articles for article (PubMed ID: 33655870)
1. Evaluation of Early Administration of Insulin Glargine in the Acute Management of Diabetic Ketoacidosis.
Mohamed A; Ploetz J; Hamarshi MS
Curr Diabetes Rev; 2021; 17(8):e030221191986. PubMed ID: 33655870
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial.
Thammakosol K; Sriphrapradang C
Diabetes Obes Metab; 2023 Mar; 25(3):815-822. PubMed ID: 36479786
[TBL] [Abstract][Full Text] [Related]
3. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children.
Shankar V; Haque A; Churchwell KB; Russell W
Intensive Care Med; 2007 Jul; 33(7):1173-1178. PubMed ID: 17508198
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study.
Doshi P; Potter AJ; De Los Santos D; Banuelos R; Darger BF; Chathampally Y
Acad Emerg Med; 2015 Jun; 22(6):657-62. PubMed ID: 26013711
[TBL] [Abstract][Full Text] [Related]
5. Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen.
Harrison VS; Rustico S; Palladino AA; Ferrara C; Hawkes CP
Pediatr Diabetes; 2017 Dec; 18(8):742-748. PubMed ID: 27807910
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Early Insulin Glargine Administration in the Treatment of Pediatric Diabetic Ketoacidosis.
Welter KJ; Marquez JL; Marshik PL; Yao MV; Bickel ES
J Pediatr Pharmacol Ther; 2023; 28(2):149-155. PubMed ID: 37139251
[TBL] [Abstract][Full Text] [Related]
7. Glargine versus regular insulin protocol in feline diabetic ketoacidosis.
Zeugswetter FK; Luckschander-Zeller N; Karlovits S; Rand JS
J Vet Emerg Crit Care (San Antonio); 2021 Jul; 31(4):459-468. PubMed ID: 33945208
[TBL] [Abstract][Full Text] [Related]
8. Audit of diabetic ketoacidosis management at a tertiary hospital in Johannesburg, South Africa.
Thomas S; Mohamed NA; Bhana S
S Afr Med J; 2019 May; 109(6):407-411. PubMed ID: 31266558
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the treatment of diabetic ketoacidosis in the medical intensive care unit.
Fusco N; Gonzales J; Yeung SY
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S177-82. PubMed ID: 26582306
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
[TBL] [Abstract][Full Text] [Related]
11. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
Razavi Z; Maher S; Fredmal J
Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
[TBL] [Abstract][Full Text] [Related]
12. Acute Management of Diabetic Ketoacidosis in Adults at 3 Teaching Hospitals in Canada: A Multicentre, Retrospective Cohort Study.
Galm BP; Bagshaw SM; Senior PA
Can J Diabetes; 2019 Jul; 43(5):309-315.e2. PubMed ID: 30579737
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Variable Versus Fixed Insulin Infusion Rate on Resolution of Diabetic Ketoacidosis.
Bohach N; Moorman JM; Cunningham B; Mullen C; Fowler M
Am J Ther; 2023 May; 30(3):e179-e185. PubMed ID: 36867515
[TBL] [Abstract][Full Text] [Related]
14. Euglycemic Diabetic Ketoacidosis: Experience with 44 Patients and Comparison to Hyperglycemic Diabetic Ketoacidosis.
Sell J; Haas NL; Korley FK; Cranford JA; Bassin BS
West J Emerg Med; 2023 Nov; 24(6):1049-1055. PubMed ID: 38165186
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Short Intensive Care Unit Stay for Patients with Diabetic Ketoacidosis Using a Novel Emergency Department-Based Resuscitation and Critical Care Unit.
Zhou VL; Shofer FS; Desai NG; Lorincz IS; Mull NK; Adler DH; Greenwood JC
J Emerg Med; 2019 Feb; 56(2):127-134. PubMed ID: 30401511
[TBL] [Abstract][Full Text] [Related]
16. A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosis.
Gallagher BR; Mahony OM; Rozanski EA; Buob S; Freeman LM
J Vet Emerg Crit Care (San Antonio); 2015; 25(2):234-9. PubMed ID: 25546713
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison.
Vidyasagar K; Chandrasekar B; Chhabra M; Bhansali A; Bansal D
Clin Ther; 2020 Aug; 42(8):e115-e139. PubMed ID: 32798057
[TBL] [Abstract][Full Text] [Related]
18. Incidence and long-term outcomes of critically ill adult patients with moderate-to-severe diabetic ketoacidosis: retrospective matched cohort study.
Azevedo LC; Choi H; Simmonds K; Davidow J; Bagshaw SM
J Crit Care; 2014 Dec; 29(6):971-7. PubMed ID: 25220529
[TBL] [Abstract][Full Text] [Related]
19. ADDRESSING PITFALLS IN MANAGEMENT OF DIABETIC KETOACIDOSIS WITH A STANDARDIZED PROTOCOL.
Karajgikar ND; Manroa P; Acharya R; Codario RA; Reider JA; Donihi AC; Salata RA; Korytkowski MT
Endocr Pract; 2019 May; 25(5):407-412. PubMed ID: 30657360
[No Abstract] [Full Text] [Related]
20. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
Alemzadeh R; Parton EA; Holzum MK
Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
